New drug shows promise for calming bipolar mania in hospitalized patients
NCT ID NCT06419582
Summary
This study tested whether an experimental drug called BHV-7000 could safely and effectively treat acute manic episodes in people with bipolar I disorder. Researchers enrolled 274 hospitalized patients and compared BHV-7000 against a placebo over 21 days, measuring changes in manic symptoms. The goal was to see if this new treatment could reduce the severity of manic episodes more effectively than no active medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Research Center, Inc.
Anaheim, California, 92805, United States
-
Arch Clinical Trials
St Louis, Missouri, 63141, United States
-
Atlanta Center for Medical Research
Atlanta, Georgia, 30331, United States
-
CBH Health
Gaithersburg, Maryland, 20877, United States
-
CIT IE
Riverside, California, 92506, United States
-
CIT LA
Bellflower, California, 90706, United States
-
CenExel iResearch, LLC
Decatur, Georgia, 30030, United States
-
CenExel iResearch, LLC
Savannah, Georgia, 31405, United States
-
Cenexel - RCA
Hollywood, Florida, 33024, United States
-
Cenexel CNS
Garden Grove, California, 92845, United States
-
Cenexel CNS
Torrance, California, 90504, United States
-
Community Clinical Research, Inc.
Austin, Texas, 78754, United States
-
Floridian Neuroscience Institute
Miami Lakes, Florida, 33016, United States
-
Hassman Research Institute
Marlton, New Jersey, 08053, United States
-
InSite Clinical Research, LLC
DeSoto, Texas, 75115, United States
-
LCC Medical Research Inst
Miami, Florida, 33126, United States
-
Midwest Clinical Research Center
Dayton, Ohio, 45417, United States
-
NBCR
North Canton, Ohio, 44720, United States
-
NRC Research Institute
Orange, California, 92868, United States
-
Neuroscience Research Institute
West Palm Beach, Florida, 33407, United States
-
Pillar Clinical Research
Chicago, Illinois, 60641, United States
-
Pillar Clinical Research, LLC
Bentonville, Arkansas, 72712, United States
-
Pillar Clinical Research, LLC
Richardson, Texas, 75080, United States
-
Precise Clinical Research
Flowood, Mississippi, 39232, United States
-
ProScience Research Group
Culver City, California, 90230, United States
-
RBA
Staten Island, New York, 10329, United States
-
Segal Trials - Larkin Behavioral Health Services-Inpatient & Early Phase Site
Hollywood, Florida, 33021, United States
-
Segal Trials - Miami Lakes Medical Research-Inpatient & Early Phase Site
Miami Lakes, Florida, 33016, United States
-
Synergy San Diego
Lemon Grove, California, 91945, United States
-
Uptown Research Institute
Chicago, Illinois, 60640, United States
-
WIRG
Little Rock, Arkansas, 72211, United States
-
WRN
Rogers, Arkansas, 72758, United States
Conditions
Explore the condition pages connected to this study.